ArticleScientific reports2024

Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutations.

Yoshiaki Yasutake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.